Clinical Trials Directory

Trials / Conditions / Locally Advanced Ureter Urothelial Carcinoma

Locally Advanced Ureter Urothelial Carcinoma

7 registered clinical trials studyying Locally Advanced Ureter Urothelial Carcinoma.

StatusTrialSponsorPhase
Active Not RecruitingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo
NCT04963153
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTrying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
NCT04637594
Alliance for Clinical Trials in OncologyPhase 3
Active Not RecruitingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or
NCT04940299
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingImmune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
NCT04848519
Emory UniversityPhase 2
Active Not RecruitingAtezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta
NCT03237780
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advance
NCT03244384
National Cancer Institute (NCI)Phase 3